Advances in surgical biomaterials are an important step in the ongoing developments being made in the fields of tissue engineering and regenerative medicine. Progress continues to be made in stem cell research, which one day may result in new technologies that can help us regenerate our bodies, just as plants and animals do.
Hernia repair is one of the most commonly performed surgical procedures worldwide. During this procedure, the surgeon repairs the hole in the abdominal wall by sewing surrounding muscle together or by placing a patch called "mesh" over the defect.
The revolution is indeed underway.
Money married to desire, imagination and necessity has produced a technological revolution which will see incredible changes and potential. This is not about any morbid fixation, but rather about complimentary technologies. Some religious ideologists, or ethically sensitive groups, may not approve.
MycoLogics, Inc. today announced award of a Phase I SBIR grant by the Department of Health and Human Services to isolate a new class of compounds by disrupting beta(1,3)-glucan synthesis using a novel assay.
BioSurgical Innovations, Inc. is marketing new technologies in surgical biomaterials throughout Latin America that offer physicians and their patients’ alternative surgical and treatment options. These innovative products are designed to interact with living tissue and have the capacity to improve procedural efficiencies for surgeons and enhance the clinical outcomes and quality of life for their patients.